Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 39 (RNA5SP39) is a processed pseudogene related to the 5S ribosomal RNA gene. It does not produce a functional ribosomal RNA product and is classified as a non-coding RNA pseudogene.[2][3] Pseudogenes, including rRNA pseudogenes like RNA5SP39, generally arise from ancestral ribosomal RNA genes through processes such as retrotransposition or sequence duplication followed by inactivation due to mutation.[1][3] Most pseudogenes are transcriptionally inactive, but some can be expressed and may have regulatory functions in gene expression via RNA interference mechanisms or by acting as competitive endogenous RNAs; however, these roles are not universally established and no specific functional data is available for RNA5SP39 itself.[1][4][5] rRNA pseudogenes are a large and diverse family, typically bearing sequence similarity to their functional parental rRNA genes but lacking protein-coding potential and canonical rRNA roles.[8] There is no evidence that RNA5SP39 acts as a disease gene, therapeutic target, or direct clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 39 (RNA5SP39).